首页 | 本学科首页   官方微博 | 高级检索  
检索        


Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy
Authors:Charles B Stacy  Alessandro Di Rocco  Randall J Gould
Institution:(1) Department of Neurology, The Mount Sinai Medical Center, One Gustave G. Levy Place, Box 1139, 10029-6574 New York, NY, USA;(2) Department of Medicine, Beth Israel Medical Center, New York, New York, USA
Abstract:Summary Two cases of severe myeloneuropathy and macrocytic anemia associated with a low serum level of vitamin B12 after prolonged exposure to nitrous oxide are reported. In both cases, the neurological manifestations worsened initially despite B12 supplementation, al though in one case the use of methionine seemed to arrest the progression of the disease and accelerate recovery. This offers further support for the biochemical hypothesis of methionine synthetase inhibition by nitrous oxide and reproduces in man previously reported animal studies with methionine. Methionine may be an important first-line therapy in the initial treatment of neuropathy and myeloneuropathy induced by nitrous oxide, and has a hypothetical role in the treatment of subacute combined degeneration of the cord.
Keywords:Nitrous oxide  Vitamin B12  Subacute combined degeneration  Methionine  Myeloneuropathy
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号